Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Nebraska
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Mayo Clinic
University of Arizona
Yale University
US Oncology Research
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center